Explore the Benefits of the Latest Trendy Cannabinoid: Delta-10 THC
by Chane Leigh
Cannabis is still a controversial topic in the medical community. With some well-respected doctors advocating for its use, others continue to voice concerns about its addictive properties and long term effects. As researchers continue to explore cannabis as a potential treatment for chronic and terminal illnesses, some studies are focusing their efforts on the effects on Alzheimer’s treatment and symptoms. Alzheimer’s disease is the leading cause of dementia among the elderly, and with the ever-increasing size of this population, cases of Alzheimer’s disease are expected to triple over the next 50 years.
Current medications utilized today cannot stop the damage that Alzheimer’s causes to brain cells. These medications only lessen or stabilize symptoms for a limited time by affecting the chemicals involved in carrying messages among the brain’s nerve cells.
Going back through research of preliminary studies from the early 2000s, researchers became optimistic about their findings. Data has shown that THC and other compounds found in cannabis may reduce the amount of beta-amyloid in the brain. Beta-amyloid is a hallmark characteristic of Alzheimer’s and is also commonly thought to cause neurodegenerative disease. While researchers have seen some success in using cannabis to fight the formation of beta-amyloid plaques, studies are showing differing results in using it to treat the disease.
Further review of studies has revealed that a combination of CBD and THC was most effective in memory retention and was more effective than CBD alone or THC alone. These results implied that the CBD components of cannabis might be useful to treat and prevent Alzheimer’s because CBD components could suppress the main causal factors of the disease.
Antonio Currais, Ph.D., lead author of the 2016 study on THC and Alzheimer’s conducted through the University of California, San Diego. “When we were able to identify the molecular basis of the inflammatory response to amyloid-beta protein, it became clear that THC -like compounds, that the nerve cells make themselves, may be involved in protecting the cells from dying.”
A comprehensive analysis in the February 2017 edition of Frontiers in Pharmacology summarized an Australian study of CBD’s effects on Alzheimer’s. The meta-analysis states that “CBD can affect the progression of Alzheimer’s by reducing cellular harm when the nervous system becomes damaged.
MedPharm, a Colorado-based cannabis research, and formulation development company, has just recently received a Medical Marijuana Research and Development License from the City of Denver. This is the last piece in the licensing puzzle for the company to study how cannabis-based medication might impact Alzheimer’s disease and other forms of dementia. MedPharm sought the license to meet the need for better quality cannabis and dosage forms for research purposes, as researchers continually complain about the quality of the cannabis provided by the University of Mississippi.
MedPharm will administer gel capsules that contain both cannabinoids and other natural, non-cannabis-derived compounds that have been shown to have a positive effect on brain health. The company will also distribute a cannabinoid-only formulation, as well as a placebo, to compare how each formulation performs.
When going to the dispensary, it’s easy to get overwhelmed by the products and strains to choose from. There’s a ton of different strains on the shelf thanks to marketing strategies and innovative cannabis breeding. With so much information out there, it’s hard to know what to purchase when starting this journey. Let’s look at…
The University of Maryland School of Pharmacy in Baltimore is inviting students to graduate under its Medical Cannabis Master of Science (M.S.) program. Stretching over two years, the program demonstrates growing acceptance for the cannabis plant, which is currently legal in 36 U.S. states for medical purposes. The M.S. Medical Cannabis Science and Therapeutics program…
Many veterans who’ve experienced military combat often suffer and cope with post-traumatic stress disorder (PTSD). It is common for these veterans to always feel on edge, on the verge of panicking, or feeling emotionally numb. For veterans, PTSD (sometimes referred to as ‘shell shock’ or ‘combat stress’) can severely impact their livelihood. Fortunately, congressional committees…
Note: Veriheal does not support illegal drug use or illegally consuming alternative therapeutic substances, but acknowledges that it transpires because of the current illicit status. Of which we strive to change by advocating for research, legal access, and responsible consumption. One can say whatever they want about recreational drug use, but no one can deny…
Mindfulness—a meditative act that can open the door to inner peace and new perspectives—goes hand-in-hand with cannabis. Practiced by some 500 million people around the world, mindfulness, when mastered correctly, can aid you in achieving overall wellness and mental clarity. Since cannabis serves as a natural tool for introspection, reflection, and relaxation, the trichome-encrusted green…
The US Senate has proposed a bill that could potentially legalize cannabis on the federal level. Researchers have discovered the exact origins…
More places have legalized cannabis, and that means more people are growing it than ever before. Cannabis sales recently hit the $90…
Up until recently, lack of cannabis education meant that people were blissfully unaware of the fact that the plant is not limited…
